Danish drugmaker Novo Nordisk has partnered Emcure Pharmaceuticals to commercialise Poviztra, a 2.4 milligram (mg) ...
Novo Nordisk partners with Emcure to promote Wegovy, following Eli Lilly's recent collaboration with Cipla for tirzepatide in ...
The partnership comes just five months after Wegovy debuted in India, and signals Novo Nordisk’s intent to scale access ...
Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...
The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...
Our Bureau, Mumbai Monday, November 10, 2025, 12:45 Hrs [IST] ...
You’ve made your kids a protein-rich breakfast, frog-marched them into the bathroom to clean their teeth, and then called out ...
Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra, the second brand of Wegovy.
The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...
Novo Nordisk India has joined forces with Emcure Pharmaceuticals to commercialize Poviztra, a weight-loss drug, in an effort ...
Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy (semaglutide). You’re excited, you’ve done your research, and ...
After a few months on fat jabs such as Wegovy or Mounjaro, the feeling of suppression can start to wane and weight loss can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback